The Board of Trustees

Science subsists on the regular and confinding dialogue with the public. An institution that supports this exchange in the Max Planck Society is the Board of Trustees.

The main task of this Board is to advice the respective institute in political, economic and organizational matters and to foster contact to other parts of society.

The members of the Board of Trustees at the Max Planck Institute for Molecular Biomedicine for the 2025 – 2030 term of office are listed below. The new Board of Trustees will be installed at the end of 2025.

Dr. Peter Baumgart
Managing Partner, Baumgart Capital GmbH

Dr. Jan Bruder
Head of JMB 3D Consulting

Prof. Dr. Karin Busch
Institute for Integrative Cell Biology and Physiology, University of Münster

Dorothee Feller
Minister for Schools and Education, North Rhine-Westphalia

Dr. Fritz Jaeckel
Chief Executive of the North Westphalia Chamber of Industry and Commerce

Prof. Dr. Jan Ole Kriegs
Director of the LWL Museum of Natural History, Westphalian State Museum with Planetarium

Prof. Dr. Frank Ulrich Müller
Dean of the Faculty of Medicine at the University of Münster

Dr. Stefan Nacke
Member of the German Parliament

Dr. Markus Pieper
Former Member of the European Parliament

Michael Radau
Chief Executive Officer, SuperBioMarkt AG

Klaus Richter
Chairman of the Board of Directors of Sparkasse Münsterland Ost

Prof. Dr. Dr. Thomas Sternberg
Former President of the Central Committee of German Catholics (ZdK)

Lutz Stroetmann
Managing Partner, L. Stroetmann GmbH & Co. KG

Prof. Dr. Johannes P. Wessels
Rector of the University of Münster

Dr. Andrea Wilken
Project Manager, UKM Infrastructure Management Ltd.

As of November 12, 2025